Cargando…

Direct Oral Anticoagulants for the Prevention and Acute Treatment of Cancer-Associated Thrombosis

Cancer is a major risk factor for venous thromboembolism (VTE), and cancer-associated thrombosis (CAT) constitutes approximately 15–25% of all VTE cases. For decades, the standard treatment for CAT used to be daily subcutaneous low molecular weight heparin (LMWH). Data on the safety and efficacy of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Attard, Laura M, Gatt, Alex, Bertoletti, Laurent, Delluc, Aurelien, Riva, Nicoletta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9576495/ https://www.ncbi.nlm.nih.gov/pubmed/36268462 http://dx.doi.org/10.2147/VHRM.S271411

Ejemplares similares

Cancer-Associated Abdominal Vein Thrombosis
por: Muscat-Baron, Lorna, et al.
Publicado: (2023)

Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette‐based survey
por: Riva, Nicoletta, et al.
Publicado: (2020)

Direct oral anticoagulants for unusual‐site venous thromboembolism
por: Riva, Nicoletta, et al.
Publicado: (2021)

The Role of Direct Oral Anticoagulants in Treatment of Cancer-Associated Thrombosis
por: Al-Samkari, Hanny, et al.
Publicado: (2018)

Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)
por: Riva, Nicoletta, et al.
Publicado: (2019)

Postoperative Ovarian Vein Thrombosis and Treatment with Direct Oral Anticoagulant
por: Shukr, Ghadear, et al.
Publicado: (2023)

Cancer‐associated thrombosis: Role of direct oral anticoagulants
por: Ikeda, Masataka, et al.
Publicado: (2018)

Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study
por: Ageno, Walter, et al.
Publicado: (2022)

Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS)
por: Riva, Nicoletta, et al.
Publicado: (2019)

Venous thrombosis recurrence risk according to warfarin versus direct oral anticoagulants for the secondary prevention of venous thrombosis
por: Zakai, Neil A., et al.
Publicado: (2021)

Treatment with direct oral anticoagulants in patients with upper extremity deep vein thrombosis
por: Montiel, Francisco Sánchez, et al.
Publicado: (2017)

Direct oral anticoagulants for treatment of deep vein thrombosis: overview of systematic reviews
por: Brandão, Gustavo Muçouçah Sampaio, et al.
Publicado: (2018)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021)

Treatment of direct oral anticoagulants in patients with liver cirrhosis and portal vein thrombosis
por: Chun, Ho Soo, et al.
Publicado: (2021)

Direct oral anticoagulants for the treatment of splanchnic vein thrombosis: A state of art
por: Monaco, Giovanni, et al.
Publicado: (2023)

Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review protocol
por: Bose, Gauruv, et al.
Publicado: (2019)

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists
por: Fedorov, Kateryna, et al.
Publicado: (2021)

The Role of Direct Oral Anticoagulants in Cancer-Associated Thrombosis According to the Current Literature
por: Nana, Petroula, et al.
Publicado: (2021)

Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
por: Wilks, Mailey L.
Publicado: (2022)

Effectiveness and Safety of Oral Anticoagulants in the Treatment of Acute Venous Thromboembolism: A Nationwide Comparative Cohort Study in France
por: Bertoletti, Laurent, et al.
Publicado: (2022)

Thrombosis Prevention without Anticoagulation
por: Schmaier, Alvin H.
Publicado: (2014)

Functional lupus anticoagulant testing in a large retrospective cohort of thrombosis patients with direct oral anticoagulants
por: Reda, Sara, et al.
Publicado: (2020)

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis
por: Nery, Filipe, et al.
Publicado: (2017)

Newer Oral Anticoagulants in the Treatment of Acute Portal Vein Thrombosis in Patients with and without Cirrhosis
por: Priyanka, P., et al.
Publicado: (2018)

Effect of anticoagulants on fibrin clot structure: A comparison between vitamin K antagonists and factor Xa inhibitors
por: Gauer, Julia S., et al.
Publicado: (2020)

Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients
por: Song, Andrew B, et al.
Publicado: (2019)

Recent Advances in Anticoagulant Treatment of Immune Thrombosis: A Focus on Direct Oral Anticoagulants in Heparin-Induced Thrombocytopenia and Anti-Phospholipid Syndrome
por: Carré, Julie, et al.
Publicado: (2021)

Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study
por: van de Munckhof, Anita, et al.
Publicado: (2023)

Efficacy and safety of direct oral anticoagulants for secondary prevention of cancer associated thrombosis: a meta-analysis of randomized controlled trials
por: Desai, Ruchi, et al.
Publicado: (2020)

Direct Oral Anticoagulants and Cancer-Associated Thrombosis Management. Where Do We Stand in 2019?
por: Ramacciotti, Eduardo, et al.
Publicado: (2019)

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence?
por: Biolato, Marco, et al.
Publicado: (2022)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

To Anticoagulate or Not to Anticoagulate to Prevent Arterial Thrombosis During Systemic Cancer Therapy
por: Spaccarotella, Carmen, et al.
Publicado: (2023)

Comparison of Treatment Result Between Anticoagulation Alone and Catheter-Directed Thrombolysis Plus Anticoagulation in Acute Lower Extremity Deep Vein Thrombosis
por: Choi, Young Jin, et al.
Publicado: (2019)

Anticoagulant treatment satisfaction with warfarin and direct oral anticoagulants for venous thromboembolism
por: Fang, Margaret C., et al.
Publicado: (2021)

Direct oral anticoagulants versus low molecular weight heparins for the treatment of cancer-associated thrombosis: a cost-effectiveness analysis
por: Wumaier, Kaidireyahan, et al.
Publicado: (2021)

Direct oral anticoagulants for the treatment and prevention of venous thromboembolism in patients with cancer: current evidence
por: García-Escobar, I., et al.
Publicado: (2020)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Direct Oral Anticoagulant Therapy for Isolated Distal Deep Vein Thrombosis Associated with Cancer in Routine Clinical Practice
por: Ogino, Yutaka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1n26fsr0qmtd96gcptlhojnf0o